| Name | Title | Contact Details |
|---|
Nunn'S Hospital Supplies Inc is a Rome, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cambia Health Solutions is a family of companies headquartered in Portland, Oregon, working to create a person-focused and economically sustainable health care system. Through our health plans, innovative technology and strategic investments, we are delivering consumer-centric solutions that: • help people achieve better health and well-being • make health care more available, affordable and accessible • are easily understood by everyone We put people at the heart of everything we do. Our company reaches more than 70 million Americans nationwide, including more than two million people in the Pacific Northwest who are enrolled in our regional health plans.
Tekia is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Marathon Kids is a nonprofit organization, headquartered in Austin, TX, that is dedicated to improving the health of children by providing them with the motivation, tools and support to live happier, healthier lifestyles. Marathon Kids started out with the simple mission to introduce children to the joy of running, but it has evolved into the only evidence-based running/walking program for elementary-school kids in the United States. We`ve stood up to rigorous tests to prove that our program mitigates the negative health effects of a sedentary lifestyle and ardently pushes for access around the country. The vast majority of kids don`t get the 60 minutes of physical activity they need each day. Marathon Kids running clubs are proven effective—even transformational—for millions of kids, families, organizations and schools.
Since our beginning in 1948, the Framingham Heart Study, under the direction of the National Heart, Lung and Blood Institute (NHLBI), formerly known as the National Heart Institute, has been committed to identifying the common factors or characteristics that contribute to cardiovascular disease (CVD). We have followed CVD development over a long period of time in three generations of participants.